Tumor heterogeneity: next-generation sequencing enhances the view from the pathologist's microscope.
作者信息
Aparicio Samuel, Mardis Elaine
出版信息
Genome Biol. 2014;15(9):463. doi: 10.1186/s13059-014-0463-6.
Abstract
摘要
相似文献
1
Tumor heterogeneity: next-generation sequencing enhances the view from the pathologist's microscope.
Genome Biol. 2014;15(9):463. doi: 10.1186/s13059-014-0463-6.
2
Integrating next-generation sequencing into clinical cancer diagnostics.
Expert Rev Mol Diagn. 2013 Sep;13(7):647-50. doi: 10.1586/14737159.2013.820551.
3
Advancing Cancer Research and Medicine with Single-Cell Genomics.
Cancer Cell. 2020 Apr 13;37(4):456-470. doi: 10.1016/j.ccell.2020.03.008.
4
More Pitfalls Related to Next-generation Sequencing (NGS).
Am J Clin Oncol. 2016 Aug;39(4):424. doi: 10.1097/COC.0000000000000280.
5
Next generation sequencing applications in cancer research.
Cancer Lett. 2013 Nov 1;340(2):149-50. doi: 10.1016/j.canlet.2013.05.026. Epub 2013 Jun 11.
6
Cancer heterogeneity and signaling network-based drug target.
Pharmacogenomics. 2013 Aug;14(11):1243-6. doi: 10.2217/pgs.13.113.
7
Bioinformatics Data Analysis of Next-Generation Sequencing Data from Heterogeneous Tumor Samples.
Methods Mol Biol. 2017;1633:185-192. doi: 10.1007/978-1-4939-7142-8_12.
8
Next-generation companion diagnostics: promises, challenges, and solutions.
Arch Pathol Lab Med. 2015 Jan;139(1):11-3. doi: 10.5858/arpa.2014-0063-ED.
9
Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer.
Oncotarget. 2016 May 3;7(18):26107-19. doi: 10.18632/oncotarget.8431.
10
Computing tumor trees from single cells.
Genome Biol. 2016 May 26;17(1):113. doi: 10.1186/s13059-016-0987-z.
引用本文的文献
1
NestedBD: Bayesian inference of phylogenetic trees from single-cell copy number profiles under a birth-death model.
Algorithms Mol Biol. 2024 Apr 29;19(1):18. doi: 10.1186/s13015-024-00264-4.
2
Assessing the performance of methods for cell clustering from single-cell DNA sequencing data.
PLoS Comput Biol. 2023 Oct 12;19(10):e1010480. doi: 10.1371/journal.pcbi.1010480. eCollection 2023 Oct.
3
Insights into breast cancer phenotying through molecular omics approaches and therapy response.
Cancer Drug Resist. 2019 Sep 19;2(3):527-538. doi: 10.20517/cdr.2018.009. eCollection 2019.
4
Multi-staged gene expression profiling reveals potential genes and the critical pathways in kidney cancer.
Sci Rep. 2022 May 4;12(1):7240. doi: 10.1038/s41598-022-11143-6.
5
Current perspectives on exosomes in the diagnosis and treatment of hepatocellular carcinoma (review).
Cancer Biol Ther. 2021 Apr 3;22(4):279-290. doi: 10.1080/15384047.2021.1898728. Epub 2021 Apr 13.
6
Methods for copy number aberration detection from single-cell DNA-sequencing data.
Genome Biol. 2020 Aug 17;21(1):208. doi: 10.1186/s13059-020-02119-8.
7
Towards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions.
J Transl Med. 2017 Jan 31;15(1):22. doi: 10.1186/s12967-017-1125-8.
8
Profiling of Small Nucleolar RNAs by Next Generation Sequencing: Potential New Players for Breast Cancer Prognosis.
PLoS One. 2016 Sep 15;11(9):e0162622. doi: 10.1371/journal.pone.0162622. eCollection 2016.
9
Altered expression pattern of circular RNAs in primary and metastatic sites of epithelial ovarian carcinoma.
Oncotarget. 2016 Jun 14;7(24):36366-36381. doi: 10.18632/oncotarget.8917.
10
Identification of Distinct Tumor Subpopulations in Lung Adenocarcinoma via Single-Cell RNA-seq.
PLoS One. 2015 Aug 25;10(8):e0135817. doi: 10.1371/journal.pone.0135817. eCollection 2015.
本文引用的文献
1
Individualizing kinase-targeted cancer therapy: the paradigm of chronic myeloid leukemia.
Genome Biol. 2014 Sep 17;15(9):461. doi: 10.1186/s13059-014-0461-8.
2
The multitude of molecular analyses in cancer: the opening of Pandora’s box.
Genome Biol. 2014;15(9):447. doi: 10.1186/s13059-014-0447-6.
3
MicroRNA regulation of tumorigenesis, cancer progression and interpatient heterogeneity: towards clinical use.
Genome Biol. 2014;15(9):445. doi: 10.1186/s13059-014-0445-8.
4
Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer.
Genome Biol. 2014 Aug 27;15(8):428. doi: 10.1186/s13059-014-0428-9.
5
DNMT inhibitors reverse a specific signature of aberrant promoter DNA methylation and associated gene silencing in AML.
Genome Biol. 2014 Aug 30;15(8):406. doi: 10.1186/s13059-014-0406-2.
6
MBASED: allele-specific expression detection in cancer tissues and cell lines.
Genome Biol. 2014 Aug 7;15(8):405. doi: 10.1186/s13059-014-0405-3.
7
Toward better benchmarking: challenge-based methods assessment in cancer genomics.
Genome Biol. 2014 Sep 17;15(9):462. doi: 10.1186/s13059-014-0462-7.
8
Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine.
Genome Biol. 2014 Aug 27;15(8):453. doi: 10.1186/s13059-014-0453-8.
9
Cancer genomics: one cell at a time.
Genome Biol. 2014 Aug 30;15(8):452. doi: 10.1186/s13059-014-0452-9.
10
Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance.
Genome Biol. 2014 Aug 30;15(8):449. doi: 10.1186/s13059-014-0449-4.
Zotero 插件